Austin’s Texas Healthcare and Bioscience Institute (THBI) is getting a head start on generating interest in the organization’s first statewide healthcare policy summit, The Texas Healthcare and Bioscience Summit, which will be held in Austin on June 4-5, 2014. The crux of the event will be in line with what THBI seeks to accomplish in all of its efforts: to bolster the expansion of the healthcare and life science industries in Texas by bridging gaps between researchers, politicians, and the biotech industry. To this end, THBI is forging strategic partnerships with Dr. Kyle Janek — a Texas biotech veteran with vast experience in all aspects of the industry — as well as other key business stakeholders and healthcare experts, all of whom will help launch the event and lead discussion on critical biotech issues impacting research, development, and relevant public policy.
The Summit will kick off on June 4th with an opening keynote address from Dr. Janek, who currently serves as Texas Health and Human Services Commissioner. Having been installed into the position by Governor Rick Perry on September 1st of last year, Dr. Janek has already made a significant impact on public health in Texas, providing palpable leadership and strategic direction to the health and human services system in Texas at a time when the state has needed it most.
Dr. Janek sees the Texas biotech and life sciences landscape changing rapidly, and believes that THBI’s efforts, together with a well-organized summit, can make substantial progress in preparing the industry for such changes: “Healthcare in Texas is poised for rapid change, and this event is a great opportunity to have leaders from across the industry come together and discuss opportunities and solutions. Events like this one help us focus on the future and develop innovative ways to improve healthcare for everyone in our state.”
After Dr. Janek’s keynote speech, the summit will commence in earnest, featuring a wide range of specialists, researchers, and CEOs from throughout Texas and the U.S., all of whom will lead panels and discussions on granular topics related to the industry. Notable topics to be explored at the summit will include the future of Medicaid in Texas, healthcare payment reform, academic research and development and venture capital funding opportunities, according to the organization’s recent press release.
The initially released list of speakers and panelists for the event features several top biotech and life sciences personalities who frequently make headlines on BioNews Texas, including: Ronald DePinho, M.D., President of UT MD Anderson Cancer Center; John Castellani, President and CEO of Pharmaceutical Research and Manufacturers of America (PhRMA); Brian McCall, Texas State System Chancellor and former state legislator; Jacqueline Northcut, CEO of Texas BioAlliance; James Greenwood, President and CEO of Biotechnology and Industry Organization (BIO); and Billy Millwee, former Texas Medicaid Director.
Tom Kowalski, President and CEO of THBI, sees his organization as uniquely qualified to organize and administer a conference such as this one: “THBI is, and always has been, the leading public policy voice for this industry in Texas,” adding that, “Currently there is no statewide conference quite like this, and we are excited to be able to host it; it is a natural fit for us.”
The Texas Healthcare and Bioscience Summit will take place at the Renaissance Hotel in north Austin. Get additional information here.
Photo from texastribune.org